Intra-Cellular: Q2 Earnings Snapshot
In this article:
NEW YORK (AP) — NEW YORK (AP) — Intra-Cellular Therapies Inc. (ITCI) on Thursday reported a loss of $42.8 million in its second quarter.
The New York-based company said it had a loss of 45 cents per share.
The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 62 cents per share.
The biopharmaceutical company posted revenue of $110.8 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $106.6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ITCI at https://www.zacks.com/ap/ITCI
